95 results
Page 4 of 5
CORRESP
1mdq3t9fi64
27 Mar 20
Correspondence with SEC
12:00am
UPLOAD
fd4ejhvm3iq6qtce
24 Mar 20
Letter from SEC
12:00am
S-4/A
pqsonfs0
13 Mar 20
Registration of securities issued in business combination transactions (amended)
5:28pm
S-4/A
EX-10.58
f6i0 peq19yyver3b
13 Mar 20
Registration of securities issued in business combination transactions (amended)
5:28pm
CORRESP
iueawujvi8 9il
13 Mar 20
Correspondence with SEC
12:00am
UPLOAD
vbmst yiwil86e
28 Feb 20
Letter from SEC
12:00am
S-4
yi3do3l2j 39
4 Feb 20
Registration of securities issued in business combination transactions
6:26am
8-K
EX-99.1
iuq1mgjb
21 Jan 20
Ritter Pharmaceuticals, Inc. and Qualigen, Inc. Announce Merger Agreement
9:20am
425
EX-99.1
iztizb8jzryidg5 ws9
21 Jan 20
Business combination disclosure
9:19am
424B3
y3j37q9hz689ziiv b44
6 Aug 19
Prospectus supplement
4:45pm
8-K
EX-99.1
np835v7gddqs3u6j91
6 Mar 19
Ritter Pharmaceuticals Completes Enrollment in Pivotal Phase 3 Clinical Trial of RP-G28 in Patients with Lactose Intolerance
7:00am
8-K
EX-10.2
zw8en
2 Jul 18
Ritter Pharmaceuticals Announces Appointment of Andrew J. Ritter as Chief Executive Officer
6:01am